The US Food and Drug Administration has published a new web page with an ongoing list of artificial intelligence/machine learning-enabled (AI/ML) products that it has reviewed and allowed on the market. The site showcases the work the agency has put in to get such products to the public, especially considering their novelty and complexity.
The agency on 22 September published the page that lists 343 entries for various AI/ML products that have received 510(k) clearance, premarket approval (PMA) or de novo authorization. It goes as far back as 1997 with the 510(k) clearance of the Compumedics Sleep Monitoring System
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?